Daniel Prins
Global Study Associate Director at Acerta Pharma B.V. (A member of the AstraZeneca Group) | Utrecht, Utrecht, Netherlands
Daniel Prins’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Global Study Associate Director at Acerta Pharma B.V. (A member of the AstraZeneca Group) in April 2023 - Present
Senior Project Manager at ICON plc in July 2021 - April 2023
Senior Project Manager at Strategic Solutions Division of PRA Health Sciences in April 2020 - April 2023
Project Manager at Strategic Solutions Division of PRA Health Sciences in April 2018 - April 2020
Project Manager Clinical Research at UMC Utrecht in August 2015 - April 2018
Project officer European studies at UMC Utrecht in August 2014 - August 2015
Clinical Project Leader at QPS Netherlands B.V. in January 2014 - July 2014
Clinical Project Associate at QPS Netherlands B.V. in July 2012 - January 2014
Research assistant at QPS Netherlands B.V. in January 2012 - July 2012
student teacher at ASL huiswerk- en studiebegeleiding in January 2011 - January 2011
Rijksuniversiteit Groningen / University of Groningen, MSc
Rijksuniversiteit Groningen / University of Groningen, BSc
Acerta Pharma is a European R&D centre of the AstraZeneca group dedicated to the discovery and development of novel innovative drugs for the treatment of haematological malignancies. The company began operations in 2013 with the vision of combining cutting edge science, unique covalent technology, and an experienced, dedicated team in order to deliver novel targeted therapies for patients with cancer. In 2016 AstraZeneca took a majority stake in the company and Acerta Pharma was fully acquired by AstraZeneca in 2021. We are working to develop new treatment options for patients with specific types of blood cancer. Together with our R&D colleagues of AstraZeneca in Gaithersburg, San Francisco, Boston (US), Gothenburg (SE) and Cambridge (UK) we are committed to innovative drug discovery and development, especially in the field of haematological oncology.
Discover more about Acerta Pharma B.V. (A member of the AstraZeneca Group)
Research Scientist Drug Discovery
Research Scientist at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(May 2021 – Present)
Director of Clinical Regulatory Writing
Director Clinical and Regulatory Writing at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(May 2022 – Present)
Associate Director, Medicinal Chemistry
Associate Director, Medicinal Chemistry at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(August 2022 – Present)
Senior Scientist at Acerta Pharma
Senior Scientist at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(May 2013 – Present)
Senior Director Study Management Acerta Pharma B.V. (A member of the AstraZeneca Group)
Senior Director Study Management Acerta Pharma (AstraZeneca) at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(February 2022 – Present)
Global Study Lead at Acerta Pharma B.V. (A member of the AstraZeneca Group)
Associate Director Study Leader at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(June 2021 – Present)
What is Daniel Prins email address?
Email Daniel Prins at [email protected], [email protected] and [email protected]. This email is the most updated Daniel Prins's email found in 2026.
How to contact Daniel Prins?
To contact Daniel Prins send an email to [email protected], [email protected] or [email protected].
What company does Daniel Prins work for?
Daniel Prins works for Acerta Pharma B.V. (A member of the AstraZeneca Group).
What is Daniel Prins's role at Acerta Pharma B.V. (A member of the AstraZeneca Group)?
Daniel Prins is Global Study Associate Director
What industry does Daniel Prins work in?
Daniel Prins works in the Pharmaceuticals industry.
